Stay updated on Imatinib in Recurrent Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Imatinib in Recurrent Psoriasis Clinical Trial page.

Latest updates to the Imatinib in Recurrent Psoriasis Clinical Trial page
- Check5 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. No additional content changes are indicated.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.1%

- Check47 days agoChange DetectedA new revision entry v3.4.3 was added. The previous entry v3.4.2 was removed.SummaryDifference0.1%

- Check69 days agoChange DetectedThe page now displays Revision: v3.4.2 instead of Revision: v3.4.1, indicating a minor version update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check77 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1.SummaryDifference0.1%

- Check98 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 in the page footer.SummaryDifference0.1%

Stay in the know with updates to Imatinib in Recurrent Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Imatinib in Recurrent Psoriasis Clinical Trial page.